But in 2025, thats changing: Compounded tirzepatide was effectively banned by the FDA after March 19, 2024 Compounded semaglutide ends May 22, 2024 (unless extended) Outside of narrow exceptions, compounded GLP-1 weight loss medications are no longer permitted by the FDA
The difference between what I was and how I already am is already visible
Zhu Y, Wang K, Jia X, Fu C, Yu H, Wang Y
doi: 10.3389/fendo.2025.1613334 Received 17 April 2025 Accepted 15 August 2025 Published 02 October 2025 Volume 16 - 2025 Edited by Hong Liu, UC Davis Health, United States Reviewed by Andrei Adrian Tica, University of Medicine and Pharmacy of Craiova, Romania Tian Xia, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China Updates Copyright 2025 Ou, Wang, Zhou, Chen, Lyu, Feng and Huang